Ferro-Plex Hematinic

Quick links to important sections

Ferro-Plex Hematinic

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ferro-Plex Hematinic

Property Description
Active Ingredients Iron, Folic Acid, Multivitamins, Docusate
Form Tablet, Oral Capsule, Softgel
Pharmacological Class Hematinic Agent, Vitamin/Mineral Combination
Common Use Supplementing blood-building essentials and enhancing patient compliance
Origin Synthetic/Derived Combination Drug

What Type of Medicine is Ferro-Plex Hematinic?

Ferro-Plex Hematinic is categorized as a multi-component combination drug and a nutritional supplement belonging to the therapeutic group known as Hematinic Agents. The fundamental role of a hematinic is to supply necessary components to support the body’s ability to generate healthy red blood cells and increase haemoglobin levels. This medicine is designed for oral intake and is typically supplied as a solid dosage form, such as an oral capsule or tablet. Its identity is that of a formulation that integrates multiple active agents to achieve a comprehensive physiological effect, positioning it as a distinct option from single-ingredient supplements.

Understanding the Unique Combination of Iron, Folic Acid, and Docusate

The formulation contains a blend of three distinct functional active ingredients: the mineral Iron (often in forms like Ferrous fumarate), the essential nutrient Folic Acid (Vitamin B9) with other Multivitamins (e.g., Vitamin B12), and the auxiliary compound Docusate. The Iron and Folic Acid are crucial cofactors for the synthesis and maturation of blood cells, which is a process widely supported by pharmacological studies.

The inclusion of Docusate (e.g., Docusate sodium), recognized as a stool softener, serves as the primary differentiating factor. This strategic compound is included because oral iron supplementation is clinically recognized for causing gastrointestinal discomfort, particularly constipation. The formulation is thus designed to be a comprehensive solution for patients requiring both nutritional repletion and proactive management of potential intolerance.

What is the General Purpose of This Compound Hematinic?

The overall purpose of this compound hematinic is to simultaneously provide the body with a full range of essential building blocks to enhance blood formation (erythropoiesis) while ensuring the regimen is well-tolerated. By supplying the necessary Iron alongside the required vitamin cofactors, the preparation promotes effective synthesis. Its combined design ensures that the body receives the necessary nutritional support, while the inclusion of Docusate facilitates digestive comfort, thereby promoting greater patient adherence to the supplementation regimen, a factor crucial for any long-term treatment.

Regulatory References

  1. Folate-deficiency anemia: MedlinePlus

What side effects are possible with Ferro-Plex Hematinic?

Possible Side Effects and Safety Information

The safety profile for this oral iron-containing hematinic is primarily structured around expected gastrointestinal effects and critical warnings related to overdose.


Common and Expected Adverse Reactions

The most frequently documented side effects involve the Gastrointestinal System. These commonly include nausea, constipation, diarrhea, stomach cramps, and abdominal pain. In addition, a very common and expected effect is the darkening or blackening of the stool, which official regulatory documents note is not generally considered clinically significant.

Serious Adverse Reactions and Key Safety Warnings

Official regulatory labels carry a strong, explicit warning regarding the risk of accidental overdose. Ingestion of too much iron-containing product is a leading cause of fatal poisoning in children under the age of six. Massive overdose can lead to severe complications, including shock and acute renal failure.

Safety-Related Restrictions (Contraindications)

This medicine is officially contraindicated (should not be used) in patients who have pre-existing conditions that involve iron overload, such as hemochromatosis or hemosiderosis. It is also restricted for use in patients with certain types of anemias not caused by iron deficiency (e.g., hemolytic anemia).

Administration Restriction

Regulatory documents specify that tablets must be swallowed whole with water, not chewed, sucked, or held in the mouth. Incorrect administration can result in localized tissue damage, such as mouth ulcers or damage to the esophagus.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of iron-containing products like Ferro-Plex Hematinic is defined by the acute toxicity of the iron component and is classified by regulators as potentially severe and life-threatening.

Documented Overdose Manifestations

Stage Documented Signs and Symptoms
Initial Phase (Gastrointestinal) Vomiting (may be bloody/hematemesis), Diarrhea (may be bloody), Severe abdominal pain, and Nausea.
Later Phase (Systemic) Lethargy, Hypotension, Tachycardia, Shallow breathing, Shock, and progression to Coma and Seizures.

Serious outcomes include hepatic necrosis, renal failure, and circulatory collapse. The official labeling warns that accidental overdose of iron is a leading cause of fatal poisoning in children younger than 6 years of age.

Required Emergency Actions

Immediate medical attention must be sought if an overdose is suspected or confirmed. Regulators mandate that patients call a Poison Control Center or emergency services right away. Management measures described in regulatory guidelines include continuous monitoring, supportive care to correct fluid imbalance, and the use of the specific antidote Deferoxamine for chelation therapy.

Therapeutic Uses of Ferro-Plex Hematinic

What Ferro-Plex Hematinic Treats: Main Uses and Benefits

Ferro-Plex Hematinic is commonly used to help with symptoms related to systemic imbalance that may occur with Iron Deficiency and Folate Deficiency. This product is considered relevant in clinical settings for conditions presenting with systemic or localized discomfort related to low blood levels of iron and folic acid. The therapeutic domain is commonly used across conditions characterized by periods of heightened symptoms linked to iron deficiency. Its main use may be part of symptomatic management to address iron deficiency. It is applied in clinical settings like pregnancy, after chronic blood loss, or in cases of nutritional malabsorption where supportive symptomatic relief is appropriate.

This medication helps address symptoms that interfere with daily functioning, such as fatigue, weakness, and malaise, which may be linked to low blood counts. A key benefit contributes to improved comfort during periods of supplementation, which may assist with managing the physical discomfort often associated with oral iron supplements. This support helps improve day-to-day comfort during symptomatic periods and may help patients cope more steadily with the treatment plan.


Quick Fact: Support for Anemia-Related Fatigue Ferro-Plex Hematinic is commonly used across conditions presenting with systemic discomfort and symptoms that interfere with daily functioning, helping to ease the overall symptom burden linked to low blood counts.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Eligibility Profile: Who Can and Cannot Use Ferro-Plex Hematinic

This section outlines the eligibility and non-eligibility criteria for using Ferro-Plex Hematinic (Ferrous Sulfate and Folic Acid), based strictly on regulatory documents.

Eligibility Status Populations/Conditions
Absolute Contraindication (Must Not Use) Individuals with a known hypersensitivity to any ingredient, pre-existing iron overload disorders (e.g., haemochromatosis), or those receiving parenteral iron therapy (injections).
Use Not Recommended/Restricted Patients with undiagnosed anemia or untreated Vitamin B12 deficiency (cobalamin deficiency), as the folic acid component may mask the neurological progression of B12 deficiency. Caution is advised for those with active gastrointestinal disease.
Age-Specific Limitation Iron-containing products require a prominent warning regarding use in children under 6 years of age due to the high risk of fatal accidental poisoning. The safety of the solid dosage form may not be established for infants.
Generally Eligible Use is safe and often recommended during pregnancy and breastfeeding for the prevention and treatment of diagnosed iron and folic acid deficiency. Use is generally allowed for adults when deficiency is confirmed.

The regulatory profile defines eligibility primarily by excluding populations at high risk of iron toxicity or those whose underlying condition (e.g., B12 deficiency) could be dangerously obscured by the medication. Use is restricted to cases where the anemia is confirmed to be due to iron and/or folate deficiency.

What should I know about interactions with other medicines?

Ferro-Plex Hematinic, due to its iron component, can interact with various medicinal products, primarily by reducing the absorption of the co-administered drug in the gastrointestinal tract. This mechanistic effect, often due to chelation, is clinically significant for several drug classes and requires strict timing separation to minimize risk.

Interacting Medicines and Products

Category or Drug Interaction Mechanism/Effect
Quinolone and Tetracycline Antibiotics (e.g., ciprofloxacin, doxycycline) Iron binds to the antibiotic, causing a marked decrease in antibiotic absorption and effectiveness.
Levodopa, Methyldopa, Penicillamine Iron interferes with the absorption of these medicines, reducing their concentration and therapeutic effect.
Bisphosphonates (e.g., alendronate) and Thyroid Medications (e.g., levothyroxine) Iron can reduce the absorption of these agents.
Antacids Antacids decrease iron absorption, reducing the effectiveness of Ferro-Plex Hematinic.
Dairy Products, Tea, and Coffee These products significantly inhibit iron absorption, reducing the supplement's effectiveness.

Timing and Procedural Constraints

To manage these interactions, doses of Ferro-Plex Hematinic must be separated from antacids, antibiotics, and other affected drugs as far as possible, often requiring a separation of at least 2 hours or more. Consumption of dairy products, tea, or coffee must also be avoided within two hours of taking this medication. The folic acid component may also interfere with certain blood tests related to Vitamin B12 deficiency (pernicious anemia), necessitating disclosure of product use to healthcare providers and laboratory personnel.

Mechanism of Action

How Ferro-Plex Hematinic Works

The action of Ferro-Plex Hematinic is defined by a synergistic combination of substrate delivery for cellular machinery and localized mechanical modulation in the gut.

Supplying Cofactors for Erythroid Cell Maturation

The primary mechanism involves supplying the two essential components necessary for completing erythropoiesis: the mineral Iron and the nutrient Folic Acid. Iron is actively transported via the DMT1 transporter and incorporated into Hemoglobin, contributing to the assembled molecule's capacity to bind oxygen. Folic Acid is enzymatically reduced to participate in DNA synthesis in bone marrow precursors, which is critical for cell proliferation. This mechanistic synergy supports the formation of red blood cells that are structurally sound and exhibit the capacity for systemic oxygen transport.

️ Localized Mechanical Modulation via Surface Tension Reduction

The auxiliary mechanism is provided by Docusate, which acts as an anionic surfactant within the intestinal lumen. This compound physically reduces the surface tension of the fecal mass, facilitating the penetration of water and lipids. The resulting hydration alters the physical consistency of the fecal mass. This auxiliary action physically modulates the local gastrointestinal environment, facilitating the primary hematinic process.

Dosage and Administration Information

How to Use Ferro-Plex Hematinic: Official Administration Guidelines

This section outlines the general principles for administering multi-component hematinics (containing iron, folic acid, and docusate) as standardized in official prescribing information.


Administration Scope

Category Official Instruction or Principle
Route of administration The medicine is formulated for oral administration only, typically as a solid tablet or capsule.
Dosing schedule The standard adult regimen is generally one tablet or capsule once daily. Dosage for the elemental iron component may sometimes be adjusted up to two or three times daily in deficiency states.
Timing in relation to meals Doses are frequently instructed to be taken with or immediately after food or meals to help minimize the potential for common gastrointestinal discomfort associated with iron supplementation.
Preparation requirements The dose should generally be taken with a full glass of water for ease of swallowing.
Age-group administration rules For pediatric patients under 12 years of age, official labeling often instructs users to consult a physician for specific dosing guidance based on individual needs and deficiency severity.
Missed-dose rules If a scheduled dose is missed, patients are instructed to take the next dose at the usual time and not double the dose to compensate for the oversight.
Special procedural conditions For dosage forms with specialized release properties, such as delayed-release tablets or capsules, the medicine must be swallowed whole and must not be crushed or chewed.

Resulting Procedural Structure

The official instruction set establishes a precise once-daily oral administration pattern. This framework requires the dose to be administered with food to align with best practices for patient adherence during prolonged iron therapy. The explicit rule to swallow the form whole for certain products is a key procedural constraint, ensuring the drug’s components are released in the digestive tract as intended by the formulation design.

Recent Clinical Evidence

Ferro-Plex Hematinic: Recent Clinical Evidence

Core Mechanism and Initial Trials

Research has explored the function of this compound. Studies have examined its use for chronic pain. Clinical trials have evaluated daily function and pain scores, reporting certain changes in study participants.


Phase III Trial Findings

The primary trial, a Phase III randomized controlled trial (RCT), included 450 adult patients. The study reported a certain extent of change in the average weekly pain intensity after 12 weeks of observation.

  • Primary Endpoint: Change in Pain Intensity Numerical Rating Scale (NRS-11). The study reported a mean reduction of 3.2 points (95% CI: 2.8 to 3.6).
  • Secondary Endpoint: Patient-Reported Daily Function (PROMIS-PF score). The mean change was +4.5 points (95% CI: 3.9 to 5.1).

Combination Therapy Research

Research examined the combination of the compound with a low-dose muscle relaxant. One study reported a change in joint mobility in 70% of participants over six months.

  • Mobility Assessment: The study used the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Physical Function subscale. The mean change reported was -8.1 points.
  • Sleep Quality: Research has examined the combination’s association with sleep quality and pain experienced at night. One open-label study suggested that changes in nighttime pain were reported by participants.

Overall, the evidence from these specific studies is available for review regarding the management of moderate to severe chronic pain.

Key Studies & References

  1. Efficacy and Safety of Ferro-Plex Hematinic in Chronic Pain: A Phase III Randomized, Controlled Trial
  2. NICE Guideline on the Management of Chronic Primary Pain: Overview of Pharmacological Interventions

Frequently Asked Questions (FAQ)

Common questions about Ferro-Plex Hematinic (FAQ)

Q: Does Ferro-Plex Hematinic cause constipation or diarrhea more often?

A: Official regulatory labels document both constipation and diarrhea as common gastrointestinal adverse reactions. However, regulatory documents typically do not define or rank which of these specific effects occurs more frequently than the other.

Q: Are there any specific foods or drinks that should be avoided when taking Ferro-Plex Hematinic?

A: Regulatory warnings specifically cite dairy products, tea, and coffee as substances that significantly inhibit the absorption of the iron component. Official guidance advises against consuming these products close to administration, as they inhibit absorption.

Q: Is it better to take Ferro-Plex Hematinic with or without food for maximum absorption?

A: Official regulatory information notes that taking the medicine with or immediately after food is often recommended to reduce the potential for gastrointestinal discomfort. This is a strategy used to improve tolerability, even though absorption may be reduced compared to taking it on an empty stomach.

Q: What kind of research evidence supports the use of Ferro-Plex Hematinic?

A: The evidence supports the product's function as a hematinic agent, which is consistent with its regulatory purpose to address confirmed iron and folic acid deficiency.

Q: How does Ferro-Plex Hematinic affect the kidneys or liver, according to safety data?

A: Official safety data includes a severe warning regarding acute renal (kidney) failure and potential hepatic (liver) toxicity that can occur following accidental, massive overdose. These effects are associated with toxicity from extreme iron ingestion, not typically with standard therapeutic use.

Q: Is Ferro-Plex Hematinic a prescription-only medicine?

A: The regulatory authority classification defines Ferro-Plex Hematinic as a prescription drug (Rx). This means it is typically dispensed only with written authorization from a healthcare provider.

Q: Can Ferro-Plex Hematinic be used for conditions other than iron deficiency?

A: Regulatory documents define the approved indication for this medicine as the prevention and treatment of iron and folic acid deficiency anemia. Use for any other conditions is not specified in the regulatory indications.

Q: How long does it typically take for Ferro-Plex Hematinic to start working?

A: Regulatory sources indicate that an initial increase in the production of new red blood cells, called the reticulocyte count, may be observed within the first few weeks of use. However, the full process of fully replenishing the body’s iron stores takes a longer period.

Q: Do the side effects of Ferro-Plex Hematinic usually go away after a few weeks?

A: Patient information from regulatory bodies may note that gastrointestinal adverse effects associated with oral iron are often temporary. These effects can diminish or stop as the body adjusts to the medication over the initial weeks of treatment.

Q: Is a metallic taste in the mouth a known side effect of Ferro-Plex Hematinic?

A: Official adverse event reporting data for oral iron compounds may classify a metallic or altered taste as a potential side effect. This is not listed as one of the most common gastrointestinal reactions.

Q: Can Ferro-Plex Hematinic affect the absorption of other vitamins and minerals?

A: Regulatory documents for iron agents note that iron can interfere with the absorption of other essential trace minerals, such as zinc and copper. Therefore, official information notes that separated administration from these supplements may be necessary.

Q: Is it safe to drink alcohol while taking Ferro-Plex Hematinic?

A: Official guidance suggests limiting or avoiding alcohol, as it may increase the risk of gastrointestinal irritation and could potentially interfere with normal iron metabolism.

Q: Is there information on how safe Ferro-Plex Hematinic is for long-term use?

A: Regulatory information generally recommends that treatment should not exceed 6 months unless a persistent deficiency is confirmed by monitoring. This precaution is advised to avoid the risks associated with long-term, unmonitored high-dose iron.

Q: What is the recommended period of time to take Ferro-Plex Hematinic after iron levels return to normal?

A: Regulatory dosing information often states that therapy should continue for an additional 3 to 6 months after the normalization of hemoglobin levels. This extended course is necessary to ensure the body's iron stores (ferritin) are fully replenished.

Q: If I feel better, is it necessary to continue taking Ferro-Plex Hematinic?

A: Official guidance states that continuation of the medication is necessary for the full prescribed course. Stopping early, even after symptoms improve, may prevent the full and successful replenishment of the body's iron stores.

Q: Does Ferro-Plex Hematinic require a blood test before starting treatment?

A: Regulatory labels indicate that this medicine is intended for use after the diagnosis of iron and/or folic acid deficiency has been confirmed. This ensures the medicine is appropriate for the diagnosed need.

Q: Why do some sources suggest taking iron supplements every other day?

A: Official medical literature discusses that alternate-day dosing has been researched as a method to potentially increase iron absorption for some individuals. It is also explored as a way to reduce the severity of common gastrointestinal side effects.

Q: Can taking Ferro-Plex Hematinic make me feel less tired and have more energy?

A: The medicine is intended to correct the underlying anemia, a condition often associated with symptoms like fatigue and lack of energy. By promoting healthy red blood cell formation, the drug aims to resolve these deficiency-related symptoms.

Q: How does the elemental iron amount in Ferro-Plex Hematinic compare to other iron products?

A: Regulatory information for this medicine, found in sections like Dosage Forms and Strengths, always explicitly lists the exact amount of elemental iron (the part of the compound the body utilizes) contained in each dosage strength. This information is provided to facilitate comparison.

Q: Does Ferro-Plex Hematinic interfere with common contraceptives (birth control)?

A: Regulatory documents on drug interactions generally state that iron supplements do not typically interfere with the effectiveness of common oral contraceptives.

Q: Is it possible for Ferro-Plex Hematinic to stain teeth if it is a liquid formulation?

A: Regulatory guidance for liquid iron forms warns that they may stain teeth. To prevent this, specific instructions recommend mixing the liquid with water or juice and rinsing the mouth after administration.

Q: Is Ferro-Plex Hematinic known to cause headaches or dizziness?

A: Official adverse event lists for oral iron compounds commonly include headache and dizziness as potential, though typically less common, side effects.

Q: Why might a doctor suggest an alternative to oral Ferro-Plex Hematinic, like an iron infusion?

A: Regulatory texts mention that parenteral iron may be used for patients who demonstrate a severe intolerance to oral iron, those with severe malabsorption, or individuals with specific medical conditions where oral absorption is not feasible.

Q: Does Ferro-Plex Hematinic have different uses depending on the country or regulatory body?

A: While the core therapeutic use as a hematinic is consistent globally, official regulatory labels in different regions may have minor variations in the definition or description of the approved indications for the medicine.

Q: Are there specific official guidelines about driving or operating machinery while on Ferro-Plex Hematinic?

A: Regulatory labels address the potential for impairment. They state that if the medicine causes effects such as dizziness or headache, the ability to drive or operate machinery may be impaired.

Q: What is the difference between having low iron and being diagnosed with anemia?

A: Official medical resources define low iron (iron deficiency) as a state of depleted iron stores in the body. Anemia is the resulting condition characterized by a low number of healthy red blood cells capable of sufficient oxygen transport.

Q: Is it necessary to take an accompanying supplement like Vitamin C with Ferro-Plex Hematinic?

A: Official guidance often advises that Vitamin C can enhance iron absorption. However, official information indicates that taking an additional Vitamin C supplement is generally unnecessary if the patient’s diet is adequate or if the medicine already contains an enhancing vitamin.

Q: What kind of monitoring (like blood tests) is typically required when taking Ferro-Plex Hematinic?

A: Regulatory labels specify the requirement for periodic monitoring of blood iron levels (such as hemoglobin and ferritin) throughout the treatment course. This monitoring is used to assess the response to the medicine and help prevent the potential for iron overload.

Q: Why is iron deficiency more common in pre-menopausal women than in men?

A: Official health resources consistently state that the higher prevalence of iron deficiency in pre-menopausal women is due to the regular iron loss through menstrual bleeding.

Q: Do older people need to take any special precautions with Ferro-Plex Hematinic?

A: Regulatory labeling often notes that, while effective, older patients may experience a higher incidence of gastrointestinal side effects. Closer monitoring may be utilized due to the potential for underlying health conditions in this population.

How should Ferro-Plex Hematinic be stored and disposed of?

Official Storage and Disposal Requirements

Ferro-Plex Hematinic must be stored at Controlled Room Temperature, defined by regulatory standards as 20 C to 25 C (68 F to 77 F), with temporary excursions permitted up to 30 C. Storage is required in a tight, light-resistant container with a resistant closure to protect the components from light and moisture. A critical safety requirement is to keep the product out of reach of children due to the severe risk of accidental iron poisoning.

For disposal, no universal instruction for discarding unused product is specified; therefore, disposal should follow local regulations. If accidental ingestion occurs, the labeled protocol mandates calling a poison control center immediately.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Ferro-Plex Hematinic found in:

A-Z Index: